FDA.reportPublic FDA data

Alevazol

Manufacturer
Capital Pharmaceutical, LLC
Effective date
2025-12-12
Label type
HUMAN OTC DRUG LABEL
Version
7
Source
full-release
Hydrated at
2026-06-01 01:25:31

Label at a glance#

ProductAlevazol
Active ingredientCLOTRIMAZOLE
Label structure12 sections

Indications and uses

Clears up most tinea cruris, candida albicans or tinea corporis. For effective relief of itching, scaling, cracking, burning, redness, soreness & irritation. For discomfort, scaly skin between the toes or burning feet.

Dosage and administration

Clean the affected area and dry thoroughly. Apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor. Supervise children in the use of this product. For athlete’s foot and ringworm: use daily for 4 weeks. For Candida Albicans use daily for 2 weeks. For athletes foot: Pay special attention to spaces between toes; wear well fitting, ventilated shoes and change s...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Alevazol Drug Facts

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Clotrimazole

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

  • Clears up most tinea cruris, candida albicans or tinea corporis.
  • For effective relief of itching, scaling, cracking, burning, redness, soreness & irritation.
  • For discomfort, scaly skin between the toes or burning feet.

Warning.

WARNINGS SECTION

  • For external use only.

When Using This Product

OTC - WHEN USING SECTION

  • Avoid contact with eyes.

Stop Use and Ask a Doctor if.

OTC - STOP USE SECTION

  • Irritation occurs
  • There is no improvement within 4 weeks (for athletes foot and ringworm) or within 2 weeks (for jock itch)

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

  • If swallowed get medical help or contact a Poison Control Center right away.

Directions.

DOSAGE & ADMINISTRATION SECTION

  • Clean the affected area and dry thoroughly.
  • Apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor. Supervise children in the use of this product.
  • For athlete’s foot and ringworm: use daily for 4 weeks.
  • For Candida Albicans use daily for 2 weeks.
  • For athletes foot: Pay special attention to spaces between toes; wear well fitting, ventilated shoes and change shoes and socks at least one daily.
  • If condition persists longer, consult a doctor.
  • This product is not effective on the scalp or nails

Other Information.

  • Store at 15deg –30deg C (59deg-86deg F)
  • Lot No and Exp Date: See Crimp of tube.

Inactive Ingredients.

INACTIVE INGREDIENT SECTION

  • Aloe Vera Gel, Ceresin Wax, Dried Aluminum Hydroxide Gel USP (for Coloring), Lanolin USP, Mineral Oil USP, Snow White PET-G USP.

Question? Comments?

OTC - QUESTIONS SECTION

  • Call 1-(614) 638-4622

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Alevazol with ACTIVEaloe®
CLOTRIMAZOLE 1% OINTMENT
ANTIFUNGAL

PRINCIPAL DISPLAY PANEL Alevazol with ACTIVEaloe® CLOTRIMAZOLE 1% OINTMENT ANTIFUNGALPRINCIPAL DISPLAY PANEL Alevazol with ACTIVEaloe® CLOTRIMAZOLE 1% OINTMENT ANTIFUNGAL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1543313Alevazol 1 % Topical OintmentPSN7
418475clotrimazole 1 % Topical OintmentPSN7
1543313clotrimazole 0.01 MG/MG Topical Ointment [Alevazol]SBD7
418475clotrimazole 0.01 MG/MG Topical OintmentSCD7
1543313Alevazol 0.01 MG/MG Topical OintmentSY7
1543313Alevazol 1 % Topical OintmentSY7
418475clotrimazole 1 % Topical OintmentSY7

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CLOTRIMAZOLE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b64d2752-34ef-378a-1f4f-8bff32b0d1aeProduct name420250626
cb7783e0-feaa-7e56-fb3b-d43b6efa77c9Product name220250121
f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6Product name220151106
f5395dd2-4395-d8c6-3477-8c2d4a2f951cProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
29978-918-602025-12-03C16284748780-19d75b9d0-19bd-f424-e053-dadaa90a57ceAlevazol
29978-918-602025-07-29C16284748780-19d75b9d0-19bd-f424-e053-dadaa90a57ceAlevazol
29978-918-602022-12-15C16284748780-19d75b9d0-19bd-f424-e053-dadaa90a57ceAlevazol
29978-918-602020-01-31C16284748780-19d75b9d0-19bd-f424-e053-dadaa90a57ceAlevazol

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
29978-918-60Alevazol56.7 g in 1 TUBEOINTMENT56.77
29978-918-60Alevazol1 in 1 CARTONOINTMENT17

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
29978-918-60GM - Gram29978-918df3c7839-2e42-416c-a0fe-0664a3e6169312015-06-09

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
CLOTRIMAZOLEACTIVE INGREDIENTG07GZ97H651
CLOTRIMAZOLEACTIVE MOIETYG07GZ97H651
ALOE VERA WHOLEINACTIVE INGREDIENTKIZ4X2EHYX1
ALUMINUM HYDROXIDEINACTIVE INGREDIENT5QB0T2IUN01
CERESININACTIVE INGREDIENTQ1LS2UJO3A1
LANOLININACTIVE INGREDIENT7EV65EAW6H1
MINERAL OILINACTIVE INGREDIENTT5L8T28FGP1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
29978-91829978-918-60

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Name, UNII, Kind table
NameUNIIKind
ALOE VERA WHOLEKIZ4X2EHYXIACT
CERESINQ1LS2UJO3AIACT
ALUMINUM HYDROXIDE5QB0T2IUN0IACT
LANOLIN7EV65EAW6HIACT
MINERAL OILT5L8T28FGPIACT
CLOTRIMAZOLEG07GZ97H65ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 8 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
LANOLINLANOLIN7EV65EAW6HOINTMENT / TOPICAL10 %w/wExact identifier — unii+route+dosage form
2 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPOINTMENT / TOPICAL9938 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
CERESINCERESINQ1LS2UJO3AOINTMENT / TOPICAL1097 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
LANOLINLANOLIN7EV65EAW6HOINTMENT / TOPICAL10 %w/wExact identifier — unii+route+dosage form
2 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPOINTMENT / TOPICAL9938 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
CERESINCERESINQ1LS2UJO3AOINTMENT / TOPICAL1097 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
ALUMINUM HYDROXIDEALUMINUM HYDROXIDE5QB0T2IUN0OINTMENT / TOPICALNAExact identifier — unii+route+dosage form
2 equally ranked IID candidates
ALUMINUM HYDROXIDEALUMINUM HYDROXIDE5QB0T2IUN0OINTMENT / TOPICALNAExact identifier — unii+route+dosage form
2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AlevazolCLOTRIMAZOLECapital Pharmaceutical, LLCedd8da89-0b83-4de6-a166-7451d00841692025-12-12WarningsExact identifier
ndc (package): 29978-918-60
ndc (product): 29978-918
ndc11 (package): 29978091860
spl id: 45c68d4c-8ea4-1022-e063-6294a90a86a0
spl set id: edd8da89-0b83-4de6-a166-7451d0084169

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.